Results
252
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
252 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ONON | US$53.74 | 2.0% | 94.9% | US$17.1b | US$58.60 | PE120.8x | E29.7% | n/a | Consumer Durables | ||
ALNY | US$248.79 | -6.0% | 52.7% | US$30.2b | US$301.21 | PS15.3x | E70.7% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$171.89 | 2.7% | 58.0% | US$53.3b | US$174.38 | PE80.3x | E46.3% | 2.2% | Diversified Financials | ||
NVDA | US$145.89 | -0.3% | 199.5% | US$3.6t | US$161.03 | PE67.4x | E23.2% | 0.03% | Semiconductors | ||
SRPT | US$110.86 | -1.4% | 32.3% | US$10.2b | US$189.86 | PE86.9x | E42.6% | n/a | Pharmaceuticals & Biotech | ||
NU | US$13.32 | -14.8% | 64.4% | US$64.7b | US$15.94 | PB8.4x | E29.0% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
BX | US$185.03 | 1.9% | 73.3% | US$225.9b | US$168.90 | PE63.9x | E27.9% | 1.8% | Diversified Financials | ||
KSPI | US$106.17 | -5.6% | 10.6% | US$20.9b | US$139.13 | PE10.3x | E23.7% | 6.5% | Diversified Financials | ||
SMCI | US$25.80 | 26.9% | -10.0% | US$16.6b | US$40.32 | PE12.5x | E24.3% | n/a | Tech | ||
DUOL | US$331.14 | 2.4% | 51.5% | US$14.2b | US$327.23 | PE167.8x | E41.6% | n/a | Consumer Services | ||
OWL | US$23.47 | 4.5% | 72.8% | US$34.9b | US$23.55 | PE124.8x | E59.2% | 3.1% | Diversified Financials | ||
NET | US$96.47 | 2.5% | 30.9% | US$33.1b | US$92.92 | PS21.1x | E25.6% | n/a | Software | ||
SN | US$95.22 | -6.7% | 100.9% | US$13.9b | US$121.69 | PE37.2x | E22.8% | 1.1% | Consumer Durables | ||
DASH | US$172.20 | -2.0% | 80.6% | US$73.2b | US$171.55 | PS7x | E56.0% | n/a | Consumer Services | ||
RYAN | US$70.88 | -1.2% | 55.2% | US$18.4b | US$73.48 | PE87.2x | E44.5% | 0.6% | Insurance | ||
VRT | US$137.54 | 10.4% | 216.0% | US$52.9b | US$139.69 | PE88.8x | E31.2% | 0.07% | Capital Goods | ||
NTNX | US$69.44 | -3.2% | 70.8% | US$18.3b | US$75.53 | PS8.7x | E85.0% | n/a | Software | ||
CVNA | US$244.50 | 1.9% | 679.9% | US$52.7b | US$245.81 | PE1848.3x | E44.9% | n/a | Retail | ||
EXE | US$98.26 | 2.2% | 20.1% | US$22.1b | US$101.95 | PE89.4x | E95.4% | 2.5% | Energy | ||
SPOT | US$470.01 | 0.6% | 159.4% | US$93.7b | US$461.97 | PE128.6x | E29.5% | n/a | Media | ||
XPEV | US$12.64 | -5.3% | -27.4% | US$11.9b | US$13.76 | PS2.3x | E63.5% | n/a | Automobiles | ||
ZS | US$200.94 | -4.2% | 5.4% | US$31.2b | US$216.91 | PS14.1x | E39.3% | n/a | Software | ||
TER | US$103.58 | -2.6% | 12.1% | US$16.7b | US$134.62 | PE32.9x | E21.7% | 0.5% | Semiconductors |